Active · per the CBE, 29 September 2026
DOLLIMMO BELGIUM logo

DOLLIMMO BELGIUM

BE0765300009

Rechtspersoon Private limited company 1 establishment

Rue Graham Bell 8, 1402 Nivelles pharmatec.be

Behind the company: ADFINITIS SRL, NEXTGEN INVEST SRL.

Active for

5 year, 6 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Tight liquidity NBB

    Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.

  • Board fully replaced NBB

    No director from three years ago is still active according to annual account 2025.

Financials

Financial year 2025

DOLLIMMO BELGIUM from Nivelles, company number BE0765300009, closed financial year 2025 with a result of € -179,928 after tax. For that financial year DOLLIMMO BELGIUM recorded a gross margin of € -28,846 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € -81,025 to € -179,928. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 1.2 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -179,928

▼ 122 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 493,840

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -407,549.

Debts at end 2025

Bank debt

€ 4.9 million

▲ € 3.7 million vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 776,915

▲ 201% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -15,128 - € -19,070 € -28,846 ▼ € 9,776
Profit after taxes € -43,920 € -68,489 € -81,025 € -179,928 ▼ € 98,902
Equity € 721,893 € 653,404 € 1,072,379 € 1,192,451 ▲ 11%
Total debts € 868,076 € 899,326 € 1,995,504 € 5,744,808 ▲ 188%
Cash € 1,145,439 € 100,255 € 549,984 € 493,840 ▼ 10%
Land & buildings € 444,276 € 552,364 € 2,504,149 € 6,310,439 ▲ 152%
Retained profit € -78,107 € -146,596 € -227,621 € -407,549 ▼ € 179,928
Bank debt € 838,302 € 838,302 € 1,200,000 € 4,852,945 ▲ € 3.7 million
Balance sheet total € 1,589,969 € 1,552,730 € 3,067,883 € 6,937,259 ▲ 126%

Key figures of DOLLIMMO BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOLLIMMO BELGIUM?

What happened at DOLLIMMO BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 179,928. Source: NBB ↗
  • ADFINITIS SRL became a director. NBB
  • Martial DOLLINGER stepped down as director. NBB
  • NEXTGEN INVEST SRL became a director. NBB
  • Claire BECKER stepped down as director. NBB
  • New establishment in Ukkel. KBO
  • Start of the company according to the CBE. KBO
  • Claire BECKER became a director. NBB

In short

From € 43,920 loss in 2022 to € 179,928 loss in 2025.

Management

Behind DOLLIMMO BELGIUM are ADFINITIS SRL and NEXTGEN INVEST SRL. The same people are also behind PHARMA FLEX. ADFINITIS SRL is also behind DOLFINANCE.

See the full network in the app

Directors

According to the 2025 annual accounts

ADFINITIS SRL

Director · represented by Martial Dollinger

Also active at: DOLFINANCE, PHARMA FLEX

since 2024

NEXTGEN INVEST SRL

Director · represented by Claire Becker

Also active at: PHARMA FLEX

since 2024

Martial DOLLINGER

Director

Also active at: DOLFINANCE, PHARMA FLEX

since 2021 · until 2024

Claire BECKER

Director

since 2021 · until 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Graham Bell 8

1402 Nivelles

2.319.451.330

Dolezlaan 480

1180 Ukkel

Active since 17 March 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

All in One SEOBootstrapCloudflare CDNJSGoogle AnalyticsGoogle FontsLightboxMapboxNginxPHPSwiperWordPressjQueryjsDelivrreCAPTCHAunpkg

Certifications & Partners

ISO 9001FEB/VBO

Hosting & Email

Email provider

Microsoft 365

Hosting

IPV1-SIA-AS, LV

Website info

HTTPS Ja
Indexable pages 14
Languages EN

Features

Webshop Blog Newsletter Contact page

Security

✓ HTTPS
✓ SPF
✓ DMARC

Details

Company number
0765.300.009
VAT number
BE 0765.300.009
Registered office
Rue Graham Bell 8, 1402 Nivelles
Names & denominations
DOLLIMMO BELGIUM
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
17 March 2021
Peppol
Active · Active since 27 Mar 2026
Contact
pharmatec.be

Frequently asked questions

What is the address of DOLLIMMO BELGIUM?
The registered office of DOLLIMMO BELGIUM is located at Rue Graham Bell 8, 1402 Nivelles.
Is DOLLIMMO BELGIUM still active?
Yes. According to the CBE (29 September 2026) DOLLIMMO BELGIUM is active, legal situation “Normale toestand”, started on 17 March 2021.
Is DOLLIMMO BELGIUM registered on Peppol?
Yes, DOLLIMMO BELGIUM is registered on the Peppol network with ID 0208:0765300009.
What is the enterprise number of DOLLIMMO BELGIUM?
The enterprise number of DOLLIMMO BELGIUM is BE0765300009.
When was DOLLIMMO BELGIUM founded?
DOLLIMMO BELGIUM was founded on 17 March 2021.
Who owns DOLLIMMO BELGIUM?
Behind DOLLIMMO BELGIUM are ADFINITIS SRL and NEXTGEN INVEST SRL. The same people are also behind PHARMA FLEX. ADFINITIS SRL is also behind DOLFINANCE.